Consensus in initial management of acute pancreatitis (3rd Edition)-Reference-Cited by-同舟云学术

Consensus in initial management of acute pancreatitis (3rd Edition)

Published:2011 Issue:6 Volume:26 Page:651-683
ISSN:0913-0071
Container-title:Suizo
language:ja
Short-container-title:Journal of the Japan Pancreas Society

Author:

SHIMOSEGAWA Tooru,ITO Tetsuhide,AKASHI Ryuukichi,IGARASHI Hisato,ISAJI Shuji,INUI Kazuo,OKAZAKI Kazuichi,KATAOKA Keisho,KAMISAWA Terumi,KAWA Shigeyuki,KITAGAWA Motoji,KIHARA Yasuyuki,SHIMIZU Kyoko,SHIRATORI Keiko,TAKEDA Kazunori,TAKEYAMA Yoshifumi,NARUSE Satoru,NISHIMORI Isao,HIROTA Masahiko,HIROTA Morihisa,FURUYA Tomoki,MASAMUNE Atsushi,MAYUMI Toshihiko,MINE Tetsuya

Publisher

Japan Pancreas Society

Reference37 articles.

1. 1) 急性膵炎診療ガイドライン2010改訂出版委員会編, 急性膵炎診療ガイドライン2010. 東京: 金原出版, 2009.

2. 2) 武田和憲, 大槻眞, 木原康之, 他. 急性膵炎重症度判定基準最終改定案の検証. 厚生労働科学研究費補助金難治性疾患克服事業難治性膵疾患に関する調査研究平成19年度研究報告書, 2008: 29-33.

3. Mortality and deterioration factors of acute pancreatitis-The multicenter analysis of death from acute pancreatitis-

4. 4) Fogel EL, Sherman S. Acute biliary pancreatitis: when should the endoscopist intervene? Gastroenterolgy 2003; 125: 229-35.

5. 5) 小川道雄, 広田昌彦, 早川哲夫, 他. 厚生省特定疾患消化器系疾患調査研究班, 難治性膵疾患分科会, 平成10年度報告書, 1999: 19-22.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of nafamostat mesylate in the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a systematic review and meta-analysis of randomized controlled trials;Scientific Reports;2023-12-27

2. Identification of Risk Factors for Phlebitis in Patients Treated with Nafamostat Mesylate;YAKUGAKU ZASSHI;2023-05-01

3. Risk of Hyperkalemia Caused by Nafamostat Mesilate in Geriatric Patients;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2020-10-10

4. The importance of nutritional management of patients with acute and chronic pancreatitis and the role of registered dieticians;Suizo;2020-04-30

5. Liver Failure Caused by Refractory Cholangitis after Operation for Hilar Cholangiocarcinoma, Which Was Treated with Intra-Arterial Antibiotic Therapy;The Japanese Journal of Gastroenterological Surgery;2019-01-01